Prime Minister Narendra Modi on Thursday accepted US President Donald Trump’s thank you note, saying that India will do everything possible to help humanity’s fight against the coronovirus disease Kovid-19.
“You completely agree with President @realDonaldTrump. Times like these bring friends closer. The India-US partnership is stronger than ever.
India will do everything possible to help humanity fight against COVID-19. We will win it together, ”PM Modi said on Twitter, tagging Trump’s tweet.
pradhaanamantree narendr modee ne guruvaar ko amerika ke raashtrapati donaald tramp ke dhanyavaad not ko sveekaar karate hue kaha ki bhaarat koronovaayaras beemaaree kovid -19 ke.
Trump on Wednesday praised PM Modi and the Indian people on Twitter, in response to the Indian government’s decision to reduce the ban on the export of the anti-malarial drug hydroxychloroquine, saying he would be a game-changer in the fight against Kovid-19 Ubiquitous epidemic.
ALSO READ: PM Modi asks to focus on COVID-19, abandon new parliament building plan: DMK
“Extraordinary times also require close collaboration between friends. Thanks to India and the Indian people for the HCQ decision. Will not be forgotten! Thank you to Prime Minister @narendramodi for your strong leadership in helping not only India, but humanity in this fight! “The US President said in his tweet.
During a phone call on Saturday, Trump had asked PM Modi to put a stay on the US order of anti-malaria drug, of which India is the major manufacturer. India tightened its grip on Tuesday.
As of Wednesday night, more than 14,600 Americans had lost their lives due to coronavirus and more than 4.3 million have tested positive for the dreaded disease. Scientists and medical fraternities are racing against time to find a vaccine and a therapeutic solution.
India is the world’s largest producer of hydroxychloroquine, producing about 70 percent of the world’s supply. The demand for the drug, which is also used by patients with arthritis, was boosted after a small placebo-controlled clinical trial in China that anti-malarial medication shortened the duration and resulted in patients with cough, fever and Reduced the severity of pneumonia.
ALSO READ: Coronavirus: Restriction on burial visits during Shab-e-Barat in West Bengal
With mild and moderate disease.
India has banned the export of hydroxychloroquine and it is ready on 25 March. The ban was expanded last week to cover exports from Special Economic Zones, including pending orders from the US.
